Nasdaq Biotechnology Ishares (IBB) 300.81 $IBB
After Yesterday's Decline of 1.65%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - 1 hr 32 mins ago
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $298.04 to a high of $309.36. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $303.15 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 300.81 (-5.04)
iShares Nasdaq Biotechnology Index Falls 1.65% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - 1 hr 33 mins ago
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $298.04 to a high of $309.36. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $303.15 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 300.81 (-5.04)
Biotechs to Follow in 2015 off Fresh Insider Moves
ACCESSWIRE - Tue Jan 06, 9:00AM CST
NEW YORK, NY / ACCESSWIRE / January 6, 2015 / Insider moves are always interesting to equity traders no matter where they occur, but more than any other sector, insider buys tend to inspire the most chatter around biotech. This is mostly due to the esoteric science and trial statistics that often determine the fate of a firm, which company and other biotech insiders tend to know more about than even premium hedge fund operators.
ADXS: 7.99 (-0.68), SGEN: 31.45 (-1.60), GILD: 97.65 (+0.86), OPK: 9.91 (-0.15), MRK: 60.32 (+2.28), IBB: 300.81 (-5.04), AGIO: 111.43 (+2.56), TEVA: 54.93 (-0.16), CELG: 110.51 (-1.42)
Biotech off to a good start on first trading day of 2015
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 8:57AM CST
BIB: 123.06 (-4.28), IBB: 300.81 (-5.04)
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially
SA Editors - Seeking Alpha - Tue Dec 30, 6:05AM CST
Today we present the fifth piece in Seeking Alpha's Positioning for 2015 series. This year we have once again asked experts on a range of different asset classes and investing strategies to offer their vision for the coming year and beyond....
BIIB: 334.65 (-2.09), SPY: 199.82 (-1.90), PTLA: 27.06 (-0.76), PCYC: 119.85 (-0.12), GILD: 97.65 (+0.86), ACHN: 12.81 (-0.51), MRK: 60.32 (+2.28), EW: 127.02 (-0.76), IBB: 300.81 (-5.04), HQH: 31.41 (+0.17), REGN: 396.89 (-15.58), CELG: 110.51 (-1.42)
Analyzing The First Trust Health Care AlphaDEX ETF: How Did It Do It?
Stanford Chemist - at Seeking Alpha - Mon Dec 29, 10:40AM CST
PSCH: 58.11 (-0.76), IBB: 300.81 (-5.04), FXH: 59.43 (-0.45), XLV: 68.05 (-0.23)
TherapeuticsMD Is a Top Stock Under $10 for 2015: David Peltier
at The Street - Mon Dec 29, 9:35AM CST
Here's why the stock may blossom.
SON: 42.54 (-0.32), LMT: 188.40 (-0.89), GE: 24.07 (-0.53), TMP: 51.21 (-2.06), TXMD: 4.09 (-0.12), XBI: 184.30 (-4.70), IBB: 300.81 (-5.04), BTN: 4.12 (-0.12)
Biotech Weekly: Charts And Themes Present Mildly Bullish Outlook Into 2015
Daniel Ward - at Seeking Alpha - Mon Dec 29, 7:13AM CST
GILD: 97.65 (+0.86), XBI: 184.30 (-4.70), IBB: 300.81 (-5.04)
Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.
George Budwell, The Motley Fool - Motley Fool - Sun Dec 28, 12:05PM CST
Source: Flickr via user Derek Gavey. Pharmaceutical companies have had some of the best-performing stocks over the last couple of years thanks to an innovation boom that has produced a host of new game-changing drugs, from Gilead Sciences ' ...
ESRX: 83.28 (-0.94), GILD: 97.65 (+0.86), MRK: 60.32 (+2.28), IBB: 300.81 (-5.04), CVS: 94.23 (+0.07), ABBV: 64.33 (-0.32), GSK: 41.68 (-0.23), NVS: 91.67 (-0.78)
3 Stocks Poised for Eye-Popping Gains in 2015
George Budwell, The Motley Fool - Motley Fool - Sat Dec 27, 6:27AM CST
Source: Flicker via 401kcalculator.org The stock market has been on fire since the start of 2012. Biotech companies, though, have posted particularly impressive gains, markedly outperforming the broader markets during this time period. The ...
OREX: 5.95 (-0.20), GILD: 97.65 (+0.86), VVUS: 2.94 (-0.10), IBB: 300.81 (-5.04), ABBV: 64.33 (-0.32), PRTA: 19.05 (-0.31), ARNA: 3.32 (-0.20)
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 83.28 (-0.94), GILD: 97.65 (+0.86), FBT: 101.17 (-1.66), BIB: 123.06 (-4.28), XBI: 184.30 (-4.70), IBB: 300.81 (-5.04), BBH: 114.70 (-1.89), ABBV: 64.33 (-0.32)
Why I Expect The Biotech Sell-Off To Continue Into 2015
Sammy Pollack - at Seeking Alpha - Wed Dec 24, 7:08AM CST
BIIB: 334.65 (-2.09), ESRX: 83.28 (-0.94), GILD: 97.65 (+0.86), IBB: 300.81 (-5.04), AMGN: 152.90 (-5.09), REGN: 396.89 (-15.58), CELG: 110.51 (-1.42)
Cramer's Mad Money - Navigator Holdings Has Been Unfairly Punished (12/23/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Dec 24, 4:37AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday December 23. Navigator Holdings (NYSE: NVGS ) Has Been Unfairly Punished . Other stock mentioned: Transocean (NYSE: RIG ) With the surge in stocks, it...
RH: 91.91 (-3.38), GD: 135.72 (+0.16), LMT: 188.40 (-0.89), HON: 98.09 (-0.23), RTN: 106.24 (-0.38), NOC: 144.16 (+0.79), KMB: 113.78 (-1.11), XOM: 89.81 (-0.48), IBB: 300.81 (-5.04), VSAT: 58.82 (-1.16), NVGS: 18.65 (-0.30), JACK: 79.68 (+0.06), RIG: 16.46 (-0.38), Q: 57.07 (-1.34), COST: 141.85 (+1.85), WAG: 76.05 (-0.49), ETN: 64.39 (-0.73), MDSO: 46.31 (-0.09), DIS: 91.89 (-0.49), WFC: 52.09 (-1.11), PLKI: 55.12 (+0.61), BA: 127.53 (-1.52), DENN: 9.80 (-0.19), CBRL: 133.99 (-3.44), GILD: 97.65 (+0.86), CVX: 108.03 (-0.05)
Jim Cramer's 'Mad Money' Recap: Here Are 10 Stocks to Buy on Strong GDP Data
at The Street - Tue Dec 23, 7:26PM CST
Kimberly-Clark, Walgreen and Starbucks are among Cramer's winners on today's GDP number.
RH: 91.91 (-3.38), EYES: 11.31 (+0.98), ETN: 64.39 (-0.73), HON: 98.09 (-0.23), KMB: 113.78 (-1.11), IBB: 300.81 (-5.04), BMY: 58.48 (-0.10), PLKI: 55.12 (+0.61), MAR: 74.67 (-0.95), BA: 127.53 (-1.52), RRC: 50.59 (-1.37), VSAT: 58.82 (-1.16), SBUX: 79.23 (-0.65), NVGS: 18.65 (-0.30), COG: 28.05 (-0.40), GILD: 97.65 (+0.86), GWPH: 69.61 (-0.97), STI: 39.08 (-1.16), COST: 141.85 (+1.85), AI: 26.17 (-0.45), WAG: 76.05 (-0.49), PSEC: 8.32 (-0.03), EPD: 33.59 (-0.81)
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 4.65% Sell Off
Comtex SmarTrend(R) - Tue Dec 23, 3:40PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $292.04 to a high of $309.94. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $306.37 on volume of 3.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 300.81 (-5.04)
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 4.65% Loss
Comtex SmarTrend(R) - Tue Dec 23, 3:39PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $292.04 to a high of $309.94. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $306.37 on volume of 3.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 300.81 (-5.04)
Investors Should Stay Long Stocks as Market Continues Hitting Highs
at The Street - Tue Dec 23, 2:01PM CST
The CNBC 'Fast Money Halftime' trading panel knows there could be some risks in 2015.
AMZN: 295.29 (-6.90), IBB: 300.81 (-5.04), ALSN: 32.44 (-0.30), BAC: 16.86 (-0.52), TLT: 131.65 (+2.33), GOOG: 501.96 (-11.91), ESRX: 83.28 (-0.94), SPY: 199.82 (-1.90), QQQ: 100.07 (-1.36), GILD: 97.65 (+0.86), DIA: 173.39 (-1.45), APA: 59.26 (-0.65), ABBV: 64.33 (-0.32), BP: 35.83 (-0.27), GOOGL: 506.64 (-12.82), IWM: 115.31 (-2.03), XLE: 75.12 (-1.12)
Inside The 2 New Innovative Biotech ETFs From BioShares
Zacks Funds - Seeking Alpha - Tue Dec 23, 2:00PM CST
The biotechnology corner of the broader health care industry has been one of the best performing U.S. sectors this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition...
BBP: 26.08 (-0.39), BBC: 27.72 (-0.86), FBT: 101.17 (-1.66), XBI: 184.30 (-4.70), IBB: 300.81 (-5.04)
Fed's Patience Puts Bulls In A Hurry
Scott Martindale - Seeking Alpha - Tue Dec 23, 11:08AM CST
U.S. stocks found support once again last week and rallied on strong volume. Of course, the main catalyst was the FOMC policy statement on Wednesday that maintained its dovish language with a pledge of considerable time before raising the fed funds...
DEF: 37.29 (-0.02), NFO: 47.40 (-0.67), PNW: 68.41 (+0.23), UTHR: 124.93 (-1.90), ED: 66.08 (+0.37), IBB: 300.81 (-5.04), LUV: 40.46 (-1.18), IYZ: 28.42 (-0.32), LYB: 74.43 (-1.61), SPY: 199.82 (-1.90), IDU: 117.50 (+0.10), IYW: 101.01 (-1.39), IYK: 102.40 (-0.59), IYJ: 102.92 (-1.15), IYH: 143.53 (-0.47), BCR: 165.56 (+0.57), IYM: 79.45 (-0.73), IYC: 133.57 (-1.06), NXPI: 72.38 (-3.62), FUTY: 30.26 (-0.01), IYF: 87.48 (-1.17), IYE: 42.56 (-0.62), PYZ: 50.84 (-0.40), SHW: 260.87 (-0.79), KNOW: 66.47 (-0.87)
Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 11:02AM CST
Gilead shares fell more than 10 percent in Monday trading following news that AbbVie and Express Scripts signed an exclusive Hepatitis C.
PBE: 49.47 (-0.80), ESRX: 83.28 (-0.94), GILD: 97.65 (+0.86), IBB: 300.81 (-5.04), BBH: 114.70 (-1.89), ABBV: 64.33 (-0.32)
After Yesterday's Decline of 1.65%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - 1 hr 32 mins ago
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $298.04 to a high of $309.36. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $303.15 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 300.81 (-5.04)
iShares Nasdaq Biotechnology Index Falls 1.65% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - 1 hr 33 mins ago
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $298.04 to a high of $309.36. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $303.15 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 300.81 (-5.04)
Biotechs to Follow in 2015 off Fresh Insider Moves
ACCESSWIRE - Tue Jan 06, 9:00AM CST
NEW YORK, NY / ACCESSWIRE / January 6, 2015 / Insider moves are always interesting to equity traders no matter where they occur, but more than any other sector, insider buys tend to inspire the most chatter around biotech. This is mostly due to the esoteric science and trial statistics that often determine the fate of a firm, which company and other biotech insiders tend to know more about than even premium hedge fund operators.
ADXS: 7.99 (-0.68), SGEN: 31.45 (-1.60), GILD: 97.65 (+0.86), OPK: 9.91 (-0.15), MRK: 60.32 (+2.28), IBB: 300.81 (-5.04), AGIO: 111.43 (+2.56), TEVA: 54.93 (-0.16), CELG: 110.51 (-1.42)
Biotech off to a good start on first trading day of 2015
Seeking Alpha - at Seeking Alpha - Fri Jan 02, 8:57AM CST
BIB: 123.06 (-4.28), IBB: 300.81 (-5.04)
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially
SA Editors - Seeking Alpha - Tue Dec 30, 6:05AM CST
Today we present the fifth piece in Seeking Alpha's Positioning for 2015 series. This year we have once again asked experts on a range of different asset classes and investing strategies to offer their vision for the coming year and beyond....
BIIB: 334.65 (-2.09), SPY: 199.82 (-1.90), PTLA: 27.06 (-0.76), PCYC: 119.85 (-0.12), GILD: 97.65 (+0.86), ACHN: 12.81 (-0.51), MRK: 60.32 (+2.28), EW: 127.02 (-0.76), IBB: 300.81 (-5.04), HQH: 31.41 (+0.17), REGN: 396.89 (-15.58), CELG: 110.51 (-1.42)
Analyzing The First Trust Health Care AlphaDEX ETF: How Did It Do It?
Stanford Chemist - at Seeking Alpha - Mon Dec 29, 10:40AM CST
PSCH: 58.11 (-0.76), IBB: 300.81 (-5.04), FXH: 59.43 (-0.45), XLV: 68.05 (-0.23)
TherapeuticsMD Is a Top Stock Under $10 for 2015: David Peltier
at The Street - Mon Dec 29, 9:35AM CST
Here's why the stock may blossom.
SON: 42.54 (-0.32), LMT: 188.40 (-0.89), GE: 24.07 (-0.53), TMP: 51.21 (-2.06), TXMD: 4.09 (-0.12), XBI: 184.30 (-4.70), IBB: 300.81 (-5.04), BTN: 4.12 (-0.12)
Biotech Weekly: Charts And Themes Present Mildly Bullish Outlook Into 2015
Daniel Ward - at Seeking Alpha - Mon Dec 29, 7:13AM CST
GILD: 97.65 (+0.86), XBI: 184.30 (-4.70), IBB: 300.81 (-5.04)
Pharma Stocks Could Be in Deep Trouble in 2015. Here's Why.
George Budwell, The Motley Fool - Motley Fool - Sun Dec 28, 12:05PM CST
Source: Flickr via user Derek Gavey. Pharmaceutical companies have had some of the best-performing stocks over the last couple of years thanks to an innovation boom that has produced a host of new game-changing drugs, from Gilead Sciences ' ...
ESRX: 83.28 (-0.94), GILD: 97.65 (+0.86), MRK: 60.32 (+2.28), IBB: 300.81 (-5.04), CVS: 94.23 (+0.07), ABBV: 64.33 (-0.32), GSK: 41.68 (-0.23), NVS: 91.67 (-0.78)
3 Stocks Poised for Eye-Popping Gains in 2015
George Budwell, The Motley Fool - Motley Fool - Sat Dec 27, 6:27AM CST
Source: Flicker via 401kcalculator.org The stock market has been on fire since the start of 2012. Biotech companies, though, have posted particularly impressive gains, markedly outperforming the broader markets during this time period. The ...
OREX: 5.95 (-0.20), GILD: 97.65 (+0.86), VVUS: 2.94 (-0.10), IBB: 300.81 (-5.04), ABBV: 64.33 (-0.32), PRTA: 19.05 (-0.31), ARNA: 3.32 (-0.20)
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 83.28 (-0.94), GILD: 97.65 (+0.86), FBT: 101.17 (-1.66), BIB: 123.06 (-4.28), XBI: 184.30 (-4.70), IBB: 300.81 (-5.04), BBH: 114.70 (-1.89), ABBV: 64.33 (-0.32)
Why I Expect The Biotech Sell-Off To Continue Into 2015
Sammy Pollack - at Seeking Alpha - Wed Dec 24, 7:08AM CST
BIIB: 334.65 (-2.09), ESRX: 83.28 (-0.94), GILD: 97.65 (+0.86), IBB: 300.81 (-5.04), AMGN: 152.90 (-5.09), REGN: 396.89 (-15.58), CELG: 110.51 (-1.42)
Cramer's Mad Money - Navigator Holdings Has Been Unfairly Punished (12/23/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Dec 24, 4:37AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday December 23. Navigator Holdings (NYSE: NVGS ) Has Been Unfairly Punished . Other stock mentioned: Transocean (NYSE: RIG ) With the surge in stocks, it...
RH: 91.91 (-3.38), GD: 135.72 (+0.16), LMT: 188.40 (-0.89), HON: 98.09 (-0.23), RTN: 106.24 (-0.38), NOC: 144.16 (+0.79), KMB: 113.78 (-1.11), XOM: 89.81 (-0.48), IBB: 300.81 (-5.04), VSAT: 58.82 (-1.16), NVGS: 18.65 (-0.30), JACK: 79.68 (+0.06), RIG: 16.46 (-0.38), Q: 57.07 (-1.34), COST: 141.85 (+1.85), WAG: 76.05 (-0.49), ETN: 64.39 (-0.73), MDSO: 46.31 (-0.09), DIS: 91.89 (-0.49), WFC: 52.09 (-1.11), PLKI: 55.12 (+0.61), BA: 127.53 (-1.52), DENN: 9.80 (-0.19), CBRL: 133.99 (-3.44), GILD: 97.65 (+0.86), CVX: 108.03 (-0.05)
Jim Cramer's 'Mad Money' Recap: Here Are 10 Stocks to Buy on Strong GDP Data
at The Street - Tue Dec 23, 7:26PM CST
Kimberly-Clark, Walgreen and Starbucks are among Cramer's winners on today's GDP number.
RH: 91.91 (-3.38), EYES: 11.31 (+0.98), ETN: 64.39 (-0.73), HON: 98.09 (-0.23), KMB: 113.78 (-1.11), IBB: 300.81 (-5.04), BMY: 58.48 (-0.10), PLKI: 55.12 (+0.61), MAR: 74.67 (-0.95), BA: 127.53 (-1.52), RRC: 50.59 (-1.37), VSAT: 58.82 (-1.16), SBUX: 79.23 (-0.65), NVGS: 18.65 (-0.30), COG: 28.05 (-0.40), GILD: 97.65 (+0.86), GWPH: 69.61 (-0.97), STI: 39.08 (-1.16), COST: 141.85 (+1.85), AI: 26.17 (-0.45), WAG: 76.05 (-0.49), PSEC: 8.32 (-0.03), EPD: 33.59 (-0.81)
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 4.65% Sell Off
Comtex SmarTrend(R) - Tue Dec 23, 3:40PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $292.04 to a high of $309.94. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $306.37 on volume of 3.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 300.81 (-5.04)
SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 4.65% Loss
Comtex SmarTrend(R) - Tue Dec 23, 3:39PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $292.04 to a high of $309.94. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $306.37 on volume of 3.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 300.81 (-5.04)
Investors Should Stay Long Stocks as Market Continues Hitting Highs
at The Street - Tue Dec 23, 2:01PM CST
The CNBC 'Fast Money Halftime' trading panel knows there could be some risks in 2015.
AMZN: 295.29 (-6.90), IBB: 300.81 (-5.04), ALSN: 32.44 (-0.30), BAC: 16.86 (-0.52), TLT: 131.65 (+2.33), GOOG: 501.96 (-11.91), ESRX: 83.28 (-0.94), SPY: 199.82 (-1.90), QQQ: 100.07 (-1.36), GILD: 97.65 (+0.86), DIA: 173.39 (-1.45), APA: 59.26 (-0.65), ABBV: 64.33 (-0.32), BP: 35.83 (-0.27), GOOGL: 506.64 (-12.82), IWM: 115.31 (-2.03), XLE: 75.12 (-1.12)
Inside The 2 New Innovative Biotech ETFs From BioShares
Zacks Funds - Seeking Alpha - Tue Dec 23, 2:00PM CST
The biotechnology corner of the broader health care industry has been one of the best performing U.S. sectors this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition...
BBP: 26.08 (-0.39), BBC: 27.72 (-0.86), FBT: 101.17 (-1.66), XBI: 184.30 (-4.70), IBB: 300.81 (-5.04)
Fed's Patience Puts Bulls In A Hurry
Scott Martindale - Seeking Alpha - Tue Dec 23, 11:08AM CST
U.S. stocks found support once again last week and rallied on strong volume. Of course, the main catalyst was the FOMC policy statement on Wednesday that maintained its dovish language with a pledge of considerable time before raising the fed funds...
DEF: 37.29 (-0.02), NFO: 47.40 (-0.67), PNW: 68.41 (+0.23), UTHR: 124.93 (-1.90), ED: 66.08 (+0.37), IBB: 300.81 (-5.04), LUV: 40.46 (-1.18), IYZ: 28.42 (-0.32), LYB: 74.43 (-1.61), SPY: 199.82 (-1.90), IDU: 117.50 (+0.10), IYW: 101.01 (-1.39), IYK: 102.40 (-0.59), IYJ: 102.92 (-1.15), IYH: 143.53 (-0.47), BCR: 165.56 (+0.57), IYM: 79.45 (-0.73), IYC: 133.57 (-1.06), NXPI: 72.38 (-3.62), FUTY: 30.26 (-0.01), IYF: 87.48 (-1.17), IYE: 42.56 (-0.62), PYZ: 50.84 (-0.40), SHW: 260.87 (-0.79), KNOW: 66.47 (-0.87)
Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 11:02AM CST
Gilead shares fell more than 10 percent in Monday trading following news that AbbVie and Express Scripts signed an exclusive Hepatitis C.
PBE: 49.47 (-0.80), ESRX: 83.28 (-0.94), GILD: 97.65 (+0.86), IBB: 300.81 (-5.04), BBH: 114.70 (-1.89), ABBV: 64.33 (-0.32)
